11th Circ. Upholds Helvetia Fraudster's Conviction

Law360, New York (February 18, 2011, 7:07 PM EST) -- The Eleventh Circuit has affirmed the judgment that put Helvetia Pharmaceuticals Inc. founder Nicholas Bachynsky behind bars for 14 years for his role in fraudulently raising $3.2 million from investors to develop an experimental cancer treatment.

In an unpublished opinion Friday, the U.S. Court of Appeals for the Eleventh Circuit upheld Bachynsky’s conspiracy, securities fraud and wire fraud convictions, finding little merit to his claims that the trial court failed to observe evidentiary standards and otherwise mishandled the case.

Following a jury trial in May 2008,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.